W.G. Shaheen & Associates Dba Whitney & CO Biogen Inc. Transaction History

W.G. Shaheen & Associates Dba Whitney & CO

$915 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$278.5 - $352.75 $41,496 - $52,559	-149 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $7,044 - $9,211	24 Added 19.2%	149 $49,000
Q1 2018 May 11, 2018	BUY	$260.13 - $367.91 $32,516 - $45,988	125 New	125 $34,000

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.63 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.58 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.3 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.16 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$810 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of W.G. Shaheen & Associates Dba Whitney & CO, based on Form 13F filings with the SEC.

News

Stay updated on W.G. Shaheen & Associates Dba Whitney & CO with notifications on news.

Account